Cholera modeling: Challenges to quantitative analysis and predicting the impact of interventions

Epidemiology

Volumn 23, Issue 4, 2012, Pages 523-530

  Grad, Yonatan H ^a,b   Miller, Joel C ^b,c   Lipsitch, Marc ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHOLERA; DISEASE TRANSMISSION; MODEL; PARAMETERS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

ANTI-BACTERIAL AGENTS; CHOLERA; DECISION SUPPORT TECHNIQUES; DISEASE OUTBREAKS; HAITI; HUMANS; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; UNCERTAINTY; VACCINATION; WATER PURIFICATION; ZIMBABWE;

EID: 84862127435     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182572581     Document Type: Article

References (63)

1. Rosenberg CE. The cholera years: the United States in 1832, 1849 and 1866. Chicago: University of Chicago Press; 1987.
2. Reyburn R, Deen JL, Grais RF, et al. The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis. 2011;5:e952.
3. Andrews JR, Basu S. Transmission dynamics and control of cholera in Haiti: an epidemic model. Lancet. 2011;377:1248-1255.
4. Bertuzzo E, Mari L, Righetto L, et al. Prediction of the spatial evolution and effects of control measures for the unfolding Haiti cholera outbreak. Geophys Res Lett. 2011;38.
5. Chao DL, Halloran ME, Longini IM Jr. Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proc Natl Acad Sci USA. 2011;108:7081-7085.
6. Mukandavire Z, Liao S, Wang J, Gaff H, Smith DL, Morris JGJr. Estimating the reproductive numbers for the 2008-2009 cholera outbreaks in Zimbabwe. Proc Natl Acad Sci USA. 2011;108:8767-8772.
7. Tuite AR, Tien J, Eisenberg M, Earn DJ, Ma J, Fisman DN. Cholera epidemic in Haiti, 2010: using a transmission model to explain spatial spread of disease and identify optimal control interventions. Ann Intern Med. 2011;154:593-601.
8. Clemens JD. Vaccines in the time of cholera. Proc Natl Acad Sci USA. 2011;108:8529-8530.
9. Koelle K, Pascual M, Yunus M. Serotype cycles in cholera dynamics. Proc Biol Sci. 2006;273:2879-2886.
10. Pascual M, Rodo X, Ellner SP, Colwell R, Bouma MJ. Cholera dynamics and El Nino-Southern Oscillation. Science. 2000;289:1766-1769.
11. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G. Refractory periods and climate forcing in cholera dynamics. Nature. 2005;436:696-700.
12. Koelle K. The impact of climate on the disease dynamics of cholera. Clin Microbiol Infect. 2009;15(suppl 1):29-31.
13. Nelson EJ, Harris JB, Glenn Morris J, Calderwood SB, Camilli A. Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol. 2009;7:693-702.
14. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995;8:48-86.
15. Codeço CT. Endemic and epidemic dynamics of cholera: the role of the aquatic reservoir. BMC Infect Dis. 2001;1:1.
16. Hartley DM, Morris JG, Smith DL. Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PLoS Med. 2006;3:e7.
17. Faruque SM, Islam MJ, Ahmad QS, et al. Self-limiting nature of seasonal cholera epidemics: role of host-mediated amplification of phage. Proc Natl Acad Sci USA. 2005;102:6119-6124.
18. Jensen MA, Faruque SM, Mekalanos JJ, Levin BR. Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci USA. 2006;103:4652-4657.
19. Colwell RR, Huq A. Environmental reservoir of Vibrio cholerae. The causative agent of cholera. Ann N Y Acad Sci. 1994;740:44-54.
20. Hornick RB, Music SI, Wenzel R, et al. The broad street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med. 1971;47:1181-1191.
21. Haas CN, Rose JB, Gerba CP. Quantitative microbial risk assessment. New York: Wiley; 1999.
22. Merrell DS, Butler SM, Qadri F, et al. Host-induced epidemic spread of the cholera bacterium. Nature. 2002;417:642-645.
23. King AA, Ionides EL, Pascual M, Bouma MJ. Inapparent infections and cholera dynamics. Nature. 2008;454:877-880.
24. Joh RI, Wang H, Weiss H, Weitz JS. Dynamics of indirectly transmitted infectious diseases with immunological threshold. Bull Math Biol. 2009; 71:845-862.
25. Bertuzzo E, Azaele S, Maritan A, Gatto M, Rodriguez-Iturbe I, Rinaldo A. On the space-time evolution of a cholera epidemic. Water Resources Res. 2008;44.
26. Bertuzzo E, Casagrandi R, Gatto M, Rodriguez-Iturbe I, Rinaldo A. On spatially explicit models of cholera epidemics. J R Soc Interface. 2009;7:321-333.
27. Tien JH, Earn DJD. Multiple transmission pathways and disease dynamics in a waterborne pathogen model. Bull Math Biol. 2010;72:1506-1533.
28. Luquero FJ, Banga CN, Remartinez D, Palma PP, Baron E, Grais RF. Cholera epidemic in Guinea-bissau (2008): the importance of "place." PLoS One. 2011;6:e19005.
29. Luque Fernández MA, Mason PR, Gray H, Bauernfeind A, Fesselet JF, Maes P. Descriptive spatial analysis of the cholera epidemic 2008-2009 in Harare, Zimbabwe: a secondary data analysis. Trans R Soc Trop Med Hyg. 2011;105:38-45.
30. Watts DJ, Muhamad R, Medina DC, Dodds PS. Multiscale, resurgent epidemics in a hierarchical metapopulation model. Proc Natl Acad Sci USA. 2005;102:11157-11162.
31. Halloran ME, Longini IM Jr, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol Rev. 1999;21:73-88.
32. Pandit CG, Pal SC, Murti GV, Misra BS, Murty DK, Shrivastav JB. Survival of Vibrio cholerae biotype El Tor in well water. Bull World Health Organ. 1967;37:681-685.
33. Pesigan TP, Plantilla J, Rolda M. Applied studies on the viability of El Tor vibrios. Bull World Health Organ. 1967;37:779-786.
34. Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2007; 274:599-604.
35. McLean AR, Blower SM. Imperfect vaccines and herd immunity to HIV. Proc Biol Sci. 1993;253:9-13.
36. Longini IM Jr., Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. Controlling endemic cholera with oral vaccines. PLoS Med. 2007;4: e336.
37. Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ. Vaccination against pandemic influenza A/H1N1v in England: a realtime economic evaluation. Vaccine. 2010;28:2370-2384.
38. Update: outbreak of cholera-Haiti, 2010. Morb Mortal Wkly Rep. 2010;59:1586-1590.
39. Update: cholera outbreak-Haiti, 2010. Morb Mortal Wkly Rep. 2010; 59:1473-1479.
40. Republic of Haiti Ministry of Public Health and Population Web Site. Available at: http://www.mspp.gouv.ht/site/index.php?optioncom-content& viewarticle&id57. Accessed June 27, 2011.
41. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966-1970.
42. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003;300:1961-1966.
43. Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol. 2004;160:509-516.
44. Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005.
45. Yang Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science. 2009;326:729-733.
46. Lessler J, dos Santos T, Aguilera X, Brookmeyer R, Cummings DA. H1N1pdm in the Americas. Epidemics. 2010;2:132-138.
47. Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature. 2004;432:904-906.
48. White LF, Wallinga J, Finelli L, et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respi Viruses. 2009;3: 267-276.
49. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-785.
50. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9:291-300.
51. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442: 448-452.
52. Germann TC, Kadau K, Longini IM Jr, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA. 2006;103:5935-5940.
53. Halloran ME, Ferguson NM, Eubank S, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA. 2008;105:4639-4644.
54. Fraser C. Estimating individual and household reproduction numbers in an emerging epidemic. PLoS ONE. 2007;2:e758.
55. Goldstein E, Paur K, Fraser C, Kenah E, Wallinga J, Lipsitch M. Reproductive numbers, epidemic spread and control in a community of households. Math Biosci. 2009;221:11-25.
56. Bacaer N, Gomes MG. On the final size of epidemics with seasonality. Bull Math Biol 2009;71:1954-1966.
57. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005; 438:355-359.
58. Smith DL, Drakeley CJ, Chiyaka C, Hay SI. A quantitative analysis of transmission efficiency versus intensity for malaria. Nat Commun. 2010; 1:108.
59. Woolhouse ME, Dye C, Etard JF, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA. 1997;94:338-342.
60. Yorke JA, Hethcote HW, Nold A. Dynamics and control of the transmission of gonorrhea. Sex Transm Dis. 1978;5:51-56.
61. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324:1557-1561.
62. Swerdlow DL, Mintz ED, Rodriguez M, et al. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet. 1992;340:28-33.
63. Box GEP. Sci Stat. JASA. 1976;71:791-799.